Key Findings in CBD Pouches Market

• By content, 10 mg-20 mg captures over 52% market share
• By type, flavored segment accounts for 88% market share
• By distribution channel, offline distribution take up around 68% market share
• North America is the largest revenue contributor with over 59% revenue share
• CBD pouches market is projected to hit the market valuation of US$ 535.62 million by 2033

To Get more Insights,  Request A Free Sample 

 From Niche to Mainstream: Six Trends Redefining the CBD Pouches Market

1. Product innovation is bifurcating to capture a wider audience. Brands are launching high-potency options, like pouches with 50mg of CBD, for seasoned users, while simultaneously offering a wide array of flavors—up to 8 from a single brand—to attract newcomers.
2. Major channel expansion is underway. Distribution is moving beyond specialty shops into mainstream retail, with some brands now in 6,000 stores. The 2024 decision in France, under 1 new policy allowing pharmacies to sell CBD, marks a pivotal shift towards wellness and medical legitimacy in the CBD pouches market.
3. Competitive landscape is trending towards aggressive scaling and consolidation. We see this in the 1 major acquisition each by giants like Aurora Cannabis and Curaleaf in 2024.
4. New entrants are scaling at an unprecedented pace; one brand launched in 2024 was already in licensing talks with 13 companies by early 2025.
5. Clinical validation is becoming a cornerstone of brand strategy, with trials involving over 178 participants boosting consumer confidence.
6. Regulatory divergence, with markets like Ukraine legalizing medical cannabis via 1 new bill while others tighten rules, is forcing companies to adopt highly adaptive global strategies.

Product Innovation and Evolving Consumer Preferences Drive Demand

Rapid product innovation tailored to increasingly sophisticated consumer preferences is defining demand for CBD pouches. Today’s consumers in the CBD pouches market  are not a monolith; their demand is segmented, requiring a diverse product portfolio. This is clearly reflected in the market offerings of 2024. For instance, the availability of pouches with a standard 10mg of CBD caters to new or cautious users. In contrast, the introduction of high-potency products, such as pouches containing 50mg of CBD for a total of 750mg per tin, directly meets the demand from experienced consumers seeking stronger effects. A standard tin typically contains 15 pouches, establishing a baseline for user experience and purchasing cycles. The demand for variety is also a powerful driver, evidenced by leading brands offering as many as 8 distinct flavors.

This innovation is backed by a robust supply chain capable of producing high-quality raw materials in the CBD pouches market. The average yield for outdoor floral hemp reached 1,757 pounds per acre in 2024, with premium indoor flower commanding prices of $600 per pound, ensuring a steady supply for premium products. Furthermore, consumer demand is heavily influenced by the perceived wellness benefits of CBD. The completion of clinical studies, such as one with 178 participants for anxiety reported in 2024, and another active trial with 120 patients for psychosis in 2025, directly fuels this wellness-driven demand. Even regulatory constraints, like the 50mg daily consumption limit set in France in 2024, paradoxically drive demand for more bioavailable and efficient formulations.

Expanding Market Access and Shifting Regulatory Landscapes

Today, CBD pouches market growth is fundamentally linked to availability, if consumers cannot find a product, they cannot buy it. Companies are aggressively expanding their retail footprints to meet this need. Cannadips’ hemp pouches are now available in 6,000 stores nationwide. This physical retail presence is complemented by strategic market entries. In late 2024, Cannadips announced its 1st cannabis pouch launch outside of its home state, entering the Arkansas market. The fierce competition among the 11 key players in the U.S. market, as identified in an August 2025 report, is a direct response to this growing demand. Even new entrants, like one that was in licensing talks with 13 companies in early 2025, are planning for rapid, wide-scale distribution from day one.

This expansion is happening in tandem with crucial regulatory shifts that unlock new channels and entire nations. The 1 new policy in France  CBD pouches market in 2024 allowing pharmacies to sell CBD created a significant, trusted new sales channel. Similarly, Ukraine passed 1 bill in February 2024 to legalize medical cannabis, creating a new market overnight. In the U.S., while federal oversight is still developing, 1 testimony from the FDA Commissioner on April 11, 2024, and 2 public comments received in June 2025 show movement toward a formal regulatory pathway, boosting industry confidence. The supply chain is scaling to meet this anticipated access, producing 20.8 million pounds of floral hemp in 2024. Finally, industry engagement at major events, like the InterTabac trade fair beginning on September 19, 2024, is critical for building the distribution networks needed to satisfy global demand.

Segmental Analysis 

By Content: 10mg-20mg Balanced Potency Propels Mainstream Adoption and Market Dominance

10 mg-20 mg holds over 52% of the market share of the CBD pouches market. The dominance of this content stems from their ability to strike an optimal balance between delivering noticeable therapeutic effects and ensuring user safety. This moderate dosage appeals to a broad consumer base, from new users seeking mild stress and anxiety relief to experienced individuals desiring a controlled, non-sedating dose for daily wellness routines. Brands are strategically formulating products in this range to meet the demand for manageable micro-dosing. For instance, FlowBlend offers pouches with a precisely measured 10mg of CBD, which is considered a safe and effective starting point for most users. Similarly, each regular tin of Cannadips contains 15 pouches with 10mg of water-dispersible CBD each. The 10 mg-20 mg dosage is widely regarded as effective for managing issues like muscle pain and improving sleep, which are common wellness goals for consumers. This potency is also suitable for beginners just entering the CBD space. The effectiveness of this dosage for therapeutic purposes without significant side effects is a key driver of its popularity and a cornerstone of the growing CBD pouches market.

The appeal of this dosage range is further enhanced by its alignment with consumer expectations for functional health products that provide reliable benefits without needing medical supervision. For example, pouches with up to 10mg of CBD are often used for treating muscular disorders and easing inflammation. Cannadips has expanded its line to include 5x strength pouches containing 50mg for more experienced users. In 2024, the 10 mg-20 mg content segment accounted for a revenue share of 50.51% in the U.S. market. This moderate range offers noticeable benefits while minimizing the risk of overconsumption for users.

• Entry-Level Appeal: Pouches with dosages up to 10 mg are particularly well-suited for beginners, allowing them to adjust intake based on tolerance.
• Targeted Formulations: Some brands infuse pouches with other natural ingredients to create products aimed at specific effects like enhanced energy or focus.
• Consumer Confidence: The approval of CBD-derived drugs like Epidiolex by the FDA has boosted overall consumer confidence in the safety of regulated CBD products.

Offline Retail Builds Trust and Dominates Distribution Channels

Despite the growth of e-commerce, offline channels with over 68% market share retain their dominance in the CBD pouches market, driven by consumer trust, immediate product access, and the value of in-person consultation. Physical retail locations, such as dispensaries, specialty stores, and pharmacies, allow consumers to see and evaluate products firsthand, which provides a sense of safety and authenticity. This is particularly important in a market where regulatory consistency is still evolving. Consumers can physically inspect packaging, verify expiration dates, and view certifications before making a purchase. The most popular offline channels are dispensaries, which are valued for their extensive product availability and ease of access for customers.

Major pharmacy chains in the CBD pouches market like CVS and Walgreens have begun offering CBD products, which is expected to increase the availability and demand for pouches. Furthermore, the role of educated staff, such as pharmacists or budtenders, is invaluable, especially for new or older consumers who may have questions about dosage and effects. This personalized guidance is something online channels cannot replicate. Many consumers discover new CBD products, including pouches, through word-of-mouth recommendations, a process often facilitated in a retail setting. The ability to purchase and use the product immediately without waiting for shipping is another significant advantage that drives sales in brick-and-mortar stores. Customer loyalty programs designed for CBD retailers are also becoming more common, encouraging repeat business through reward points and exclusive in-store deals.

• In-Store Education: Point-of-sale educational materials and pharmacist recommendations are highly valued by consumers, particularly those new to CBD.
• Targeted Loyalty: Retailers can analyze sales data to develop targeted marketing strategies and personalized loyalty programs for their customers.
• Referral Programs: Many offline retailers utilize refer-a-friend programs, offering discounts to both the referrer and the new customer to expand their local customer base.

By Type: Flavored Innovation A Key Ingredient for Market Expansion

The overwhelming preference for flavored CBD pouches, which command over 88% of sales of the CBD pouches market, is driven by the desire to make the user experience more enjoyable and palatable. Flavors effectively mask the often bitter, earthy taste of natural hemp extract, which can be a significant barrier for new or hesitant consumers. This strategy has proven highly effective in attracting a broader audience to the  market. Brands offer extensive flavor portfolios to cater to diverse tastes, ranging from refreshing options like mint and citrus to more complex profiles like coffee and fruit blends. For example, Cannadips offers a wide variety including Natural Mint, Tangy Citrus, Tropical Mango, and American Spice, which blends cinnamon, chocolate, and coffee notes. FlowBlend also provides a variety of options such as Orange Tang, Wintergreen, and Spearmint to ensure a personalized experience.

The variety of flavors in the global CBD pouches market transforms the consumption of CBD from a purely medicinal act into a more approachable and lifestyle-friendly wellness routine. This is especially appealing to younger demographics seeking customized products. The industry continues to innovate, with brands like Voon introducing flavors such as Pink Grape and Snazzy Tangerine in their hemp snus pouches. The introduction of unique seasonal flavors, such as Candy Cane, further drives consumer interest and repeat purchases. The popularity of flavors like berry and citrus is due to their invigorating qualities that enhance the overall user experience. This focus on taste has made flavored pouches a critical component of the overall product strategy in the industry.

• Strategic Expansion: In January 2020, Canndid announced a significant expansion of its product lines in the UK, including a variety of flavored pouches.
• Retail Partnerships: Cannadips Europe made its Tangy Citrus and Natural Mint flavored pouches available in COOP retail stores across Switzerland, highlighting retailer confidence in flavored options.
• Functional Flavors: Many brands are now infusing pouches with functional ingredients like vitamins or adaptogens alongside appealing flavors, aligning with broader wellness trends.

 To Understand More About this Research:  Request A Free Sample 

Regional Analysis

North America A Powerhouse of Production, Expansion, and Consumption

The North American market with over 59% market revenue contribution to the global CBD pouches market is defined by its immense production scale and aggressive corporate growth. The United States provides a formidable supply chain foundation. In 2024, the nation produced a staggering 20.8 million pounds of floral hemp. It also harvested 32,694 acres of industrial hemp in the open. This massive scale influences pricing, with premium indoor-grown CBD flower commanding $600 per pound in 2024. This robust production fuels fierce competition and expansion. One brand now boasts a retail footprint of 6,000 stores. Strategic growth is a key theme, as seen in the 1 major acquisition of Northern Green Canada by Curaleaf in May 2024.

Newer players are also scaling rapidly in the CBD pouches market. Juana Dips, a brand launched in 2024, was already in talks with 13 companies for licensing deals by early 2025. This activity is happening alongside slow but steady regulatory progress. The FDA received 2 public comments in June 2025 supporting a new regulatory category for cannabinoid hemp products. In a landmark move, Cannadips announced its 1st cannabis pouch launch into Arkansas in late 2024. The market's depth is further highlighted by ongoing research, including 1 active clinical trial at UCSD in 2025 aiming to randomize 120 patients to study CBD's effects.

Europe A Complex Mosaic of Regulation and Opportunity

Europe's CBD pouches market is characterized by a dynamic and often contradictory regulatory landscape, creating a region of immense opportunity and significant hurdles. In a progressive move, France implemented 1 new policy in 2024 authorizing pharmacies to sell CBD products. However, the country also imposed a 50mg daily consumption limit on CBD in the same year. Switzerland also updated its laws, introducing 1 new tobacco law in October 2024 that also governs industrial hemp. Italy, in contrast, took a restrictive stance, issuing 1 decree on June 27, 2024, that classified CBD as a narcotic substance, creating significant market uncertainty.

Despite these challenges, new CBD pouches markets are opening rapidly in the European region. For instance, Ukraine signed 1 historic bill into law in February 2024, legalizing medical cannabis and creating a vast new consumer base. In Malta, 2024 legal changes permit adults to cultivate up to 4 cannabis plants and possess 7 grams. These shifts create a complex but potentially rewarding environment for businesses. The importance of the region is underscored by major industry events, like the InterTabac trade fair in Germany, which began on September 19, 2024. Looking forward, the projected price for hemp in Germany for the second quarter of 2025 is $3,417 per metric ton, indicating stable raw material costs.

Asia Pacific An Emerging Market Defined by Strategic Plays

The Asia Pacific region is an emerging frontier for the CBD pouches market, defined by strategic corporate investments and nascent market development. Major North American players are making significant moves to establish an early foothold. In a key strategic play, Aurora Cannabis completed its acquisition of MedReleaf Australia in 1 major deal in February 2024. This signals strong confidence in the long-term growth potential of the Australian market. Raw material supply chains are also developing across the region. The projected price of hemp in China for the second quarter of 2025 is $1,330 per metric ton, positioning it as a potentially low-cost sourcing hub.

Scientific research is also beginning to take root across the regional CBD pouches market, which will be critical for building consumer trust and navigating regulatory pathways. In 2024, results were reported from 1 multicenter clinical trial in India that involved 178 participants studying an oral CBD solution. Regulatory frameworks across the region remain highly varied and are slowly evolving. Australia's Therapeutic Goods Administration has made 1 notable change by down-scheduling low-dose CBD. Japan updated its regulations in 2024 to allow for some CBD products, while Thailand has seen 1 major reversal in its cannabis policy. South Korea and New Zealand also maintain their own specific rules, with the latter reporting 1,500 new patients in its medical cannabis scheme in the last quarter of 2023.

Top 10 Strategic Investments and Key Approvals Redefining the Global CBD Pouches Market

• Curaleaf closed its $16M April 2024 acquisition of Northern Green Canada, integrating EU-GMP facilities to supply premium cannabis to Europe, Australia, and New Zealand, strengthening global expansion and meeting strict export standards.
• Aurora Cannabis completed its acquisition of MedReleaf Australia in February 2024 for approximately AUD$50 million, securing a leading position in Australia’s rapidly growing medical cannabis market and expanding its Asia-Pacific footprint.
• On February 15, 2024, Ukraine’s President Zelenskyy signed into law medical cannabis legalization, launching a tightly regulated program that opens a significant new European market for cannabis and CBD products.
• Germany’s Cannabis Act (CanG) took effect April 1, 2024, legalizing adult personal possession and cultivation, decriminalizing cannabis, and transforming Europe’s largest economy’s investment landscape for cannabis-related businesses.
• In April 2024, Canopy Growth secured new financing through prepayments that will reduce its term loan by US$50 million and lower annual cash interest expense by US$6.5 million, strengthening its financial position and enabling focus on core cannabis in the CBD pouches market.
• Haleon, global consumer health giant, expanded in 2024 with strong revenue growth, product launches, and geographic expansion—bolstering confidence in the mainstream potential of CBD and health-related categories.
• Avicanna, cannabinoid-based biopharma, closed a non-brokered private placement in April 2024, raising over $2.1 million to pay down debt and support commercialization and research, fueling continued growth and pipeline development.
• TJP Labs filed a patent in April 2024 for a breakthrough nicotine particulate technology designed for oral pouches, supporting innovation for both nicotine and potential CBD pouch applications.
• Jazz Pharmaceuticals’ patent for a CBD preparation to treat herpes simplex virus seizures was published in March 2024, highlighting the company’s ongoing investment in CBD’s therapeutic potential and pharmaceutical innovation.
• In June 2024, Italy’s government approved a decree classifying CBD derived from cannabis as a narcotic substance, imposing new restrictions, and significantly increasing CBD pouches market hurdles in the country.

Top Companies in the CBD Pouches Market

• Comp9
• Canndid
• Chill.com
• Chillbar
• FlowBlend
• Cannadips
• Vibe CBD+CBG
• Jake's Mint Chew
• Nicopods ehf.
• V&YOU
• Metolius Hemp Company

Market Segmentation Overview

By Type

• Flavored
• Unflavored

By Content

• Up to 10 mg
• 10 mg-20 mg
• Others

By Distribution Channel

• Online
• Offline

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Western Europe
    • The UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
• South America
  • Argentina
  • Brazil
  • Rest of South America